Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Patients With Cystic Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Cystic Fibrosis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
J Cyst Fibros 2022 Sep 01;21(5)792-799, AL Stapleton, AJ Kimple, JL Goralski, SM Nouraie, BF Branstetter, AD Shaffer, JM Pilewski, BA Senior, SE Lee, AC ZemkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.